Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report

SAGE Open Med Case Rep. 2023 Jun 14:11:2050313X231180766. doi: 10.1177/2050313X231180766. eCollection 2023.

Abstract

A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.

Keywords: Atopic dermatitis; eczema; tralokinumab; upadacitinib.

Publication types

  • Case Reports